65th ASH Annual Meeting and Exposition

The most comprehensive span of Oncology clinical development services — delivered seamlessly.

Reducing site burden and driving efficiency in clinical trials.

Services overview.

ICON understands the difference from first-hand experience, and has developed proven solutions to address all areas of cell and gene therapy development.

Helping biotech meet critical milestones.

Delivering quality data quicker for faster time to market.

ICON provide innovative paediatric strategy and operational support to all programmes that include neonates, children, adolescents, young adults, and also pregnant women.

This tool identifies common risks that may exist and affect participants' ability to enrol and remain in a trial.

ICON Laboratories’ extensive testing capabilities, combined with our clinical research experience and scientific expertise, ensure we can serve as a trusted partner in your global oncology research programs.

Innovative early phase solutions that will advance your drug development strategy.

Transforming images into information. Turning information into therapies.

Deep expertise across a broad spectrum of testing techniques.

Ensuring the highest levels of safety and accuracy in your trials.

Reducing patient burden.

Implementing solutions for on-site cryostorage, supplies, depot strategies & logistics management.

This case study presents an overview of two Bayesian model-assisted designs, particularly in how one or both can be applied to the design of an early phase oncology clinical trial.

Expedited study start-up for central radiology and clinical data review.

Development, manufacturing, regulation and market access.

Clinical advancements expanding the potential of CAR T-cell therapies.

Paving the way for diversity and inclusion in clinical trials: establishing a platform for improvement.